Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2009
11/12/2009US20090281073 Heteroaromatic derivatives useful as anticancer agents
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009CA2723798A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009CA2723775A1 Therapeutically useful substituted 1,7-diphenyl-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline compounds
11/12/2009CA2723545A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
11/12/2009CA2723080A1 Heterocyclic antiviral compounds
11/12/2009CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009CA2719288A1 Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
11/12/2009CA2712586A1 Antibacterial fluoroquinolone analogs
11/11/2009EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009EP2116544A2 Spirocyclic cyclohexane derivatives
11/11/2009EP2116543A1 Novel aminopyrimidine derivative as plk1 inhibitor
11/11/2009EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009EP2115140A1 Positively charged water-soluble prodrugs of 1h-imidazo [4, 5-c] quinolin-4-amines and related compounds with very high skin penetration rates
11/11/2009EP2114942A1 Novel aminopyrimidine derivatives as plk1 inhibitors
11/11/2009EP1979354B1 Diaza-spiro-[4, 5]-decanes useful as pesticides
11/11/2009EP1960401B1 Tricyclic amide derivatives useful for treating obesity
11/11/2009EP1841770B1 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/11/2009EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009EP1745021B1 Hydroformylation process for pharmaceutical intermediate
11/11/2009EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009EP1477186B1 Antipruritics
11/11/2009EP1313734B1 Aza heterocyclic derivatives and their therapeutic use
11/11/2009CN101578285A Condensed pyridine compound
11/11/2009CN101578284A Agent for improving insulin resistance
11/11/2009CN101578275A Anilinopiperazine derivatives and methods of use thereof
11/11/2009CN101575337A Process for extracting matrine or nicotine
11/11/2009CN101574084A 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558726C The enantiomer of tenatoprazole and the use thereof in therapy
11/11/2009CN100558722C A method for the preparation of enantiomerically pure mirtazapine
11/11/2009CN100558701C N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558409C Thiotungstate analogues and uses thereof
11/10/2009US7615639 8-Methoxy-5-methyl-1-(6-methyl-pyridin-3-yl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile, for treating HIV, viral infection; effective treating mutant HIV viruses which has drug resistance against currently available reverse transcriptase inhibitors
11/10/2009US7615638 Synthesis of grossularines-1 and analogs thereof and method of use
11/10/2009US7615633 Organic electroluminescent device and platinum compound
11/10/2009US7615567 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome
11/10/2009US7615560 tricyclic cmpounds; e.g. 3-propyl-5,6,7,8-tetrahydro-3H-benzo[4,5]-thieno[2,3-d]pyrimidin-4-ylidene amine; personal hygiene product, an oral hygiene product, a skin product or a food
11/10/2009US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615552 Fused heterocyclic compounds
11/05/2009WO2009134822A2 Fluorescent organic nanoparticles
11/05/2009WO2009134726A1 Substituted pyrimidine derivatives as histamine h4 receptor ligands
11/05/2009WO2009134616A2 Novel inhibitors of hepatitis c virus replication
11/05/2009WO2009134203A1 New peptidomimetic compounds
11/05/2009WO2009133522A1 Piperidine and pyrrolidine compounds
11/05/2009WO2009133442A1 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors
11/05/2009WO2009133314A1 1,3-dihydro-2h-pyrrolo[3,2-b]pyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
11/05/2009WO2009133135A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
11/05/2009WO2009133127A1 Fused bicyclic compounds and use thereof as pi3k inhibitors
11/05/2009WO2009133070A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/05/2009WO2009132986A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009WO2009132980A1 Pyrimidinyl pyridone inhibitors of jnk.
11/05/2009WO2009132921A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/05/2009WO2009132774A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/05/2009WO2009104147A3 Azatricyclic antibiotic compounds
11/05/2009WO2009087225A3 Pyrrolopyrimidines and pyrrolopyridines
11/05/2009WO2009065872A3 Processes for the synthesis of varenicline l-tartrate
11/05/2009WO2008075040A3 Radioactive pet agents for imaging ccr5 in vivo
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275609 Carboxamide Compounds and Methods for Using The Same
11/05/2009US20090275590 (1-azinone)-substituted pyridoindoles
11/05/2009US20090275586 Heterocyclic inhibitors of pde4
11/05/2009US20090275577 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents
11/05/2009US20090275573 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275568 Fused quinoline derivative and use thereof
11/05/2009US20090275560 Organic compounds
11/05/2009US20090275554 Aminocarboxylic acid derivative and medicinal use thereof
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275537 Certain chemical entities, compositions, and methods
11/05/2009US20090275534 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/05/2009US20090275523 Spirocyclic nitriles as protease inhibitors
11/05/2009US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009US20090274947 Imidazolidinone nitroxides as electrode materials for energy storage devices
11/05/2009US20090274674 Heterocyclic Oxime Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them
11/05/2009US20090273278 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/05/2009US20090272913 Fluorescent organic nanoparticles
11/05/2009CA2723062A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethylphenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
11/05/2009CA2723020A1 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors
11/05/2009CA2722938A1 New peptidomimetic compounds
11/05/2009CA2722487A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009CA2722347A1 Piperidine and pyrrolidine compounds
11/05/2009CA2722131A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors
11/05/2009CA2720846A1 Novel inhibitors of hepatitis c virus replication
11/05/2009CA2719868A1 Pyrimidinyl pyridone inhibitors of jnk.
11/05/2009CA2719365A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/04/2009EP2113505A1 A crystalline form III of anhydrous moxifloxacin hydrochloride and processes for the preparation thereof
11/04/2009EP2113503A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/04/2009EP1844045B1 Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1704147B1 PYRROLO[2,3-b] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009EP0879236B1 Derivatives of camptothecin for use in treating cancer
11/04/2009CN101573360A Heteroaryl compounds, compositions thereof, and methods of treatment therewith
11/04/2009CN101573335A Kinase inhibitors
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 646